HONG KONG, Oct. 16, 2025 -- CSOP Asset Management Limited (CSOP), one of Asia's premier Exchange Traded Product (ETP) issuers, announces the launch of the CSOP SK Hynix Daily (2x) Leveraged Product (stock code: 7709.HK) on the Hong Kong Stock Exchange (HKEX) on 16 October 2025. This follows the successful listing of leveraged and inverse products tracking its peer, Samsung Electronics, in May 2025. The CSOP SK Hynix Daily (2x) Leveraged Product is the world's only leveraged exchange traded product tracking SK hynix, designed to empower investors to seize the upside of one of Korea's most illustrious stocks during Asian trading hours.

As a major chip supplier to Nvidia, SK hynix's revenue soared to 22.23 trillion KRW (~equivalent to 15.86 billion USD), representing an exponential 35% year-over-year surge^[1]. In particular, 2025 is a banner year for SK hynix stock, with its return skyrocketed to a phenomenal 145% year-to-date^[2]. Riding a wave of exuberant optimism driven by rapid AI development and the booming semiconductor industry in recent years, investors are doubling down on SK hynix with an average daily turnover of 824.90 billion KRW (~ equivalent to 588.73 million USD) in 2025^[3]. Its 1-year total turnover reached 194 trillion KRW (~ equivalent to 140 billion USD), ranking #2 on Korea Exchange's top 10 list and trailing only Samsung Electronics^[4].

In order to track the two times daily performance (before fees and expenses) of the common stock of SK hynix, the product deploys a swap-based synthetic replication strategy, with listing price of about 7.8 HKD (1 USD) per unit, trading lot of 100, and management fee of 1.6% of the ETP's net asset value per year. CSOP SK Hynix Daily (2x) Leveraged Product offers an amplified exposure with several advantages, including no margin calls, zero collateral requirements, no financing costs, transparent pricing, and capped maximum leverage.

"We are pleased to announce the listing of CSOP SK Hynix Daily (2x) Leveraged Product on the Hong Kong Stock Exchange," Said Ms. Ding Chen, CEO of CSOP Asset Management. "As a leading ETF issuer in the dynamic APAC region with a 98% market share in leveraged and inverse products in Hong Kong, CSOP is committed to offering diversified investment options^[5]. The introduction of the only SK hynix leveraged exchange traded product globally in Hong Kong offers opportunities to double gains on SK hynix's meteoric growth in AI-driven semiconductor market."

Tied to innovation and growth, SK hynix's product line includes DRAM, NAND flash memory, and SRAM chips. It captured the lion's share of DRAM market with 36% in Q2 2025, surpassing all competitors^[6]. From 2020 to 2024, the compound annual growth rate (CAGR) of its yearly revenue, operating income, and net income reached 20%, 54%, and 58%^[7]. Leading the charge in semiconductor, SK hynix is ambitiously growing into a full stack AI memory provider. SK hynix has expanded into the NAND business through an 8.84 billion USD acquisition of Intel's NAND business in March 2025^[8]. Additionally, SK hynix unveiled a spending plan to keep pace with the HBM market expansion. TrendForce reported that SK hynix's 2025 capex is set to reach 23.44 trillion KRW (~equivalent to 16.97 billion USD), a striking 30% upswing over prior forecasts^[9].

About CSOP Asset Management
For over a decade, CSOP has successfully established itself as one of the leading ETF issuers in Hong Kong, with second largest AUM and demonstrated innovative product development. As of 30 September 2025, the total AUM of CSOP reached 28.6 billion USD by building a healthy ETF ecosystem and managing 62 ETPs and 4 mutual funds in Hong Kong and Singapore markets*. In 2025, 5 out of the top 10 most actively traded ETFs/ETPs in Hong Kong are managed by CSOP**.

Asia's First batch of Single Stock Leveraged & Inverse Products on HKEX

*Source: CSOP
** Source: Bloomberg, from 1 January 2025 to 30 June 2025

Disclaimer and Important Notices

NONE OF THE SUB-FUND ("SUB-FUND") MENTIONED IN THIS DOCUMENT OR MARKETING MATERIAL (THIS "DOCUMENT"), CSOP LEVERAGED AND INVERSE SERIES AND CSOP ASSET MANAGEMENT LIMITED ("CSOP") ARE AFFILIATED WITH THE CORRESPONDING COMPANY OF THE UNDERLYING SECURITY OF THE SUB-FUND (THE "CORRESPONDING COMPANY").

The Corresponding Company do not sponsor or endorse the offering of the Sub-Fund, nor is it involved with the Sub-Fund in any way. Investing in the Sub-Fund is not equivalent to investing in the Corresponding Company. Investors have no ownership rights in the Corresponding Company. Investors in the Sub-Fund will not have voting rights and will not be able to influence management of the Corresponding Company but will be exposed to the performance of the relevant security of the Corresponding Company.

This document is for general information only and does not constitute any kind of advice in any way and shall not be considered as an offer or solicitation to deal in any investment products. If you wish to receive advice on investment, please consult your professional legal, tax and financial advisers.

Investment involves risks. Investors should refer to the Prospectus and the Product Key Facts Statement for further details, including product features and risk factors. Investors should not make investment decisions based on this document alone. This document is not applicable in jurisdictions where the distribution of this document is restricted.

This document is not legally binding. CSOP takes no responsibility for the contents of this document and expressly disclaim any liability for any loss arising from or in reliance upon the whole or any part of the contents of this Document. This document does not confer upon the recipient any copyright or intellectual property rights (whether direct, indirect, or implied) in the use of the information contained herein. Any information or any part of this document should not be copied, reproduced, or distributed to any parties without the written consent of CSOP.

The Sub-Fund is a leveraged product. It is different from conventional exchange traded funds as it seeks leveraged investment results relative to the underlying stock and only on a daily basis.

The Sub-Fund is concentrated in a single underlying stock. Given the non-diversified and leveraged nature, the Sub-Fund is subject to extreme price volatility and may become non-viable within a short period. You may lose a significant portion or all of your investment within one day. Under exceptional circumstances where the Sub-Fund becomes non-viable, CSOP may use its discretion to deviate from the investment strategy or take defensive measures, which may include liquidating swap positions and suspending trading of the Sub-Fund and CSOP will issue a notice to inform investors.

The Sub-Fund is not intended for holding longer than one day as the performance of the Sub-Fund over a longer period may deviate from and be uncorrelated to the leveraged performance of the underlying stock over the period.

The Sub-Fund is designed to be used for short term trading or hedging purposes, and is not intended for long term investment.

The Sub-Fund only targets sophisticated trading-oriented investors who understand the potential consequences of seeking daily leveraged results and the associated risks and constantly monitor the performance of their holdings on a daily basis.

This document is prepared and issued by CSOP and has not been reviewed by the SFC in Hong Kong.